This month, Novo Nordisk has initiated a phase II trial with the firm's cholesterol-lowering PCSK9i inhibitor, according to the Danish pharmaceutical firm's Q2 report, published on Wednesday afternoon.
In contrast to the phase I trial, Novo Nordisk will now be testing the peptide-based drug as an oral solution using the same technology that the pharmaceutical company is using for its popular diabetes candidate Rybelsus.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
WS Audiology brings in head of EMEA region from Coloplast
The hearing aid manufacturer has appointed Coloplast’s now outgoing president for emerging markets as president for the EMEA region.
Dupixent could dominate pediatric eczema market for up to a decade, analysis finds
Sanofi and Regeneron will be able to call themselves market leaders within atopic eczema treatment for children aged 6 months to 5 for years to come, according to Globaldata.
FDA advisors support approval for Ferring's intestinal infection medicine
All signs indicate that Ferring Pharmaceuticals is on the cusp of being market authorized for its biologic candidate against C. difficile infection.
Pharmacosmos expects massive growth in four years
The company’s new chief executive has ambitions of reaching a DKK 2.5bn (USD 325m) revenue within the time frame.
The Lundbeck Foundation, ATP, LEGO asset manager join forces on secretive project
Three of Denmark’s biggest funds have come together for a yet unknown project, which includes the establishment of three new firms.
Regulatory Project Manager 
Calibration Technician 
Senior Manager, QA GMP 
Chief Business Officer 
KLIFO is looking for a Compliance Coordinator for our Glostrup office 
Scientist Radiochemistry 
Vice President, Medical Affairs 
Manager of QA, BHS Logistics 
Product specialist 
eTMF Manager 
Ambitious Business Relationship Manager for the Danish Medicines Agency 
Lab Manager 
Pharmacovigilance & Regulatory Officer 
Sales Manager Denmark